The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
about
Updates in diabetic peripheral neuropathyGender differences in nerve regeneration after sciatic nerve injury and repair in healthy and in type 2 diabetic Goto-Kakizaki ratsDiet-induced obesity and low testosterone increase neuroinflammation and impair neural functionThe effect of excess body mass on the risk of carpal tunnel syndrome: a meta-analysis of 58 studies.Exercise increases cutaneous nerve density in diabetic patients without neuropathySupervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients.Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.Chiropractic management of a 24-year-old woman with idiopathic, intermittent right-sided hemiparesthesiaThe Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.Cardiovascular Risk Factors Increase the Risks of Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: The Taiwan Diabetes StudyEffects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized studyMetabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status.Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.Exercise as Therapy for Diabetic and Prediabetic Neuropathy.High body mass and kidney dysfunction relate to worse nerve function, even in adults without neuropathy.Mediators of diabetic neuropathy: is hyperglycemia the only culprit?Peripheral neuropathy in prediabetes and the metabolic syndrome.Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study.Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome.Nerve regeneration in chitosan conduits and in autologous nerve grafts in healthy and in type 2 diabetic Goto-Kakizaki rats.The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan.Peripheral Neuropathy
P2860
Q26751252-3DC9FF13-C5DF-4401-90CD-D67AE6BF6B94Q28655616-84F4A71C-B167-43B7-9323-DDFE9753535DQ34309465-25A11B87-429D-4DB8-AC74-421149D8F729Q34495294-13F10099-A55E-48A1-95F3-64BBD554CB14Q34562889-8FCCC4E4-CDE9-4124-B5D1-427FBBABF164Q34944800-A9E601FD-3B8C-44FE-9A1D-DB26DC82B1F9Q34974523-9BB33C23-7EDB-4453-BC6E-34F19951D912Q35462231-118C4C0C-32C2-4FDD-8E81-2F3B4F18384FQ35973863-4E576A61-167F-41A1-A98E-B353E904DB7CQ36207012-D7E63688-47C1-4748-BC4F-B17BC421FA9AQ36307536-8E77E321-8032-4FE7-9760-FB2E1A843BA1Q36820599-7D2F3561-AB1C-49A1-8CA9-EB90B0C98C27Q38385395-513D9A26-DCC4-45C8-8482-A3B32A0AEA3BQ38625575-B8612352-7593-47AA-B670-B4264569DB09Q38827326-4AEAFDC2-47C7-4466-9CC4-3CDC74E0141DQ39015184-D4A76B49-42E4-47CC-ACFB-467F5A2D3C5BQ39165929-397B7A54-1CCF-48CD-AC71-515E2FC1C08CQ40136188-4AD78FD7-F42F-434B-9C0B-02FE5080ECD6Q48097245-56F3A6CD-2A55-4150-92B7-791FD1768697Q51724780-6A9B7C82-F2D1-4119-9A8F-68652C5843A7Q55237417-D335C06D-FB13-4097-81BD-31ADE3EF744AQ56385011-3D8F4D69-2A6C-4A20-96F5-0C9105F88CDF
P2860
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@en
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@nl
type
label
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@en
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@nl
prefLabel
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@en
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@nl
P2860
P356
P1433
P1476
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.
@en
P2093
Brian Callaghan
Eva Feldman
P2860
P304
P356
10.1002/ANA.23986
P577
2013-09-01T00:00:00Z